Customer Contact Center:
1-888-PLMZYME (756-9963)

Indication and Usage

Daily administration of Pulmozyme® (dornase alfa) Inhalation Solution along with standard therapies is indicated in the management of cystic fibrosis patients to improve lung function. In patients with a forced vital capacity (volume of air exhaled with maximum effort and speed) greater than or equal to 40% of predicted, daily administration of Pulmozyme has also been shown to reduce the risk of respiratory tract infections requiring the administration of injectable antibiotics.

In our pivotal study, safety and efficacy of daily administration has not been studied in patients beyond 12 months.

Important Safety Information

  • Pulmozyme should not be used in patients who are allergic to any of its ingredients. Pulmozyme should be used along with standard therapies for cystic fibrosis.
  • When starting Pulmozyme therapy, patients may experience change in or loss of their voice, discomfort in the throat, chest pain, red watery eyes, rash, dizziness, fever, or runny nose.
  • These side effects are usually mild and short-lived.

For further information, please see the Pulmozyme full Prescribing Information. If you have questions, please discuss them with your CF healthcare team.

Customer Contact Center

1-888-PLMZYME (756-9963)

Pulmozyme Access Solutions®

How CF Treatments Work and Fit into Your Routine

Treatment Regimens: How CF Treatments Work
and Fit into Your Routine

CF community video short series

Finding time to fit CF treatments into your daily schedule can often be hard to manage. In this video, hear from CF patients and caregivers on how time management is crucial, plus how they stay motivated and make health a priority. This includes an easy-to-understand explanation of CF treatments, including Pulmozyme, because an important component of treatments is understanding how they work. Before the video begins, please answer 2 quick questions that will appear on your screen, and then we would love your feedback afterwards with a brief survey.

Video Short Splash

Check out additional videos in this series on CF Living.